MedicarePartD.guide

A non-government resource built from CMS public data

Rytary on Prescription Blue Select (S5584-001)

carbidopa-levodopa extended-release

Covered, with step therapy.

Tier 4 (non-preferred drug). Quantity limit of 360 per 30 days.

$351.17
Patient pays / month, after deductible
$812.42
Patient pays / month, before the $615.00 deductible
$1,053.51
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

RYTARY 145/36.25 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $1,404.68 for a month. Other covered strengths are listed below.

Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
RYTARY 95/23.75 mg Capsule, Extended Release4$352.26ST · 360 per 30 days
RYTARY 145/36.25 mg Capsule, Extended Release4$351.17ST · 360 per 30 days
RYTARY 195/48.75 mg Capsule, Extended Release4$351.82ST · 360 per 30 days
RYTARY 245/61.25 mg Capsule, Extended Release4$367.48ST · 300 per 30 days

Other Parkinson's drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)565-1770. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5584-001